Neurona Therapeutics, Inc
Biotechnology company · South San Francisco, California, United States
Neurona Therapeutics, Inc is a biotechnology company headquartered in South San Francisco, California, United States. It has reported private securities offerings to the US SEC, most recently $102 million sold in a notice filed in 2025.
Profile compiled from public records. Is this your company? Request a correction or update
Neurona Therapeutics at a glance
Typebiotechnology company
HeadquartersSouth San Francisco, California, United States
SEC CIK1443321
What does Neurona Therapeutics do?
Private fundraising reported to the SEC
8 Form D notices; the most recent reported $101.7 million sold (2025).
Frequently asked questions about Neurona Therapeutics
Where is Neurona Therapeutics headquartered?
Neurona Therapeutics, Inc is headquartered in South San Francisco, California, United States.
What does Neurona Therapeutics do?
Neurona Therapeutics, Inc is a biotechnology company.
Similar companies
- Alector, Inc.South San Francisco, California, United States
- Vaxart, Inc.South San Francisco, California, United States
- Denali Therapeutics Inc.South San Francisco, California, United States
- Aligos Therapeutics, Inc.South San Francisco, California, United States
- PROFUSA, Inc.South San Francisco, California, United States
- Quince Therapeutics, Inc.South San Francisco, California, United States
- Allogene Therapeutics, Inc.South San Francisco, California, United States
- Sutro Biopharma, Inc.South San Francisco, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences